We serve Chemical Name:Amyl Chloroformate CAS:638-41-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:Amyl Chloroformate
CAS.NO:638-41-5
Synonyms:Pentylchlorocarbonat;Chloroformic acid amyl ester;Formic acid, chloro-, pentyl ester;Pentyl chloridocarbonate;n-Pentylchloroformate;Carbonochloridic acid, pentyl ester;Amyl Chloroformate;Pentyl carbonochloridate;Formic acid, chloro-, pentyl ester (8CI);EINECS 211-336-4;MFCD00058933
Molecular Formula:C6H11ClO2
Molecular Weight:150.603
HS Code:2915900090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:164.9±9.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.426
PSA:26.30000
Exact Mass:150.044754
LogP:3.03
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:3277
Packing Group:
Contact us for information like Pentylchlorocarbonat chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD00058933 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Carbonochloridic acid, pentyl ester Use and application,Pentyl carbonochloridate technical grade,usp/ep/jp grade.
Related News: The iLet is designed to function as three medical devices in one. It can be configured as an insulin-only bionic pancreas, a glucagon-only bionic pancreas, or a bihormonal bionic pancreas using insulin and glucagon. Amyl Chloroformate manufacturer A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. Amyl Chloroformate supplier Professionally produce and submit DMF files, and supplement data at any time during the patent challenge of formulation companies. Amyl Chloroformate vendor A week before Eli Lilly (LLY.N) disclosed to regulators that the U.S. Justice Department was investigating its New Jersey factory, the drugmaker told employees that its own inquiry, led by an outside law firm, found no evidence of wrongdoing there, according to a company memo reviewed by Reuters. Amyl Chloroformate factory Health Canada said it was planning an onsite inspection this summer and that it would not accept any product or ingredients made at the plant until the inspection was complete.
